Iodo

( DrugBank: iodo / KEGG DRUG: Iodine )

1 disease

ID	Disease name (Link within this page)	Number of trials
28	Systemic amyloidosis	2

28. Systemic amyloidosis

Clinical trials : 267 / Drugs : 241 - (DrugBank : 77) / Drug target genes : 68 - Drug target pathways : 180

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00030381 (ClinicalTrials.gov)	December 2001	14/2/2002	Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis	Phase I Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)	Primary Systemic Amyloidosis	Drug: 4'-iodo-4'-deoxydoxorubicin;Other: pharmacological study	National Cancer Institute (NCI)	NULL	Terminated	18 Years	N/A	Both	22	Phase 1	United States
2	NCT00003853 (ClinicalTrials.gov)	April 1999	1/11/1999	4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis	Phase II Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)	Multiple Myeloma and Plasma Cell Neoplasm	Drug: 4'-iodo-4'-deoxydoxorubicin	National Cancer Institute (NCI)	NULL	Completed	18 Years	N/A	Both	45	Phase 2	United States;Italy

First Previous1Next Last